Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).
此外,胰岛素抵抗和糖尿病是慢性型
炎(CHC)中纤维
进展以及对抗病毒治疗无应答的危险因素。
Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).
此外,胰岛素抵抗和糖尿病是慢性型
炎(CHC)中纤维
进展以及对抗病毒治疗无应答的危险因素。
Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS.
合并的慢性
(CHC)患者
α
扰素包括派罗欣治疗时存在
功能失代偿和死亡风险。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。